AI-generated summary
The authors compared light-emitting diode low-level light therapy (830/590 nm) with no light therapy after fractional CO2 laser resurfacing, using a split-face design in 17 patients and a separate control group of 19 patients. They report that erythema duration and erythema index on the treated side did not differ significantly from the untreated side, though erythema index changes were lower than in the CO2-only group on several days. The authors state that appropriate protocol settings should be considered to achieve a significant clinical outcome.
- Who or what was studied
- Patients with acne scars or rhytides undergoing fractional CO2 laser resurfacing; 17 in the split-face group and 19 in the CO2-only control group.
- Wavelengths
- 830, 590 nm
- Limits stated in the abstract
- The abstract describes a relatively small sample and does not report a clear statistically significant reduction in erythema duration, erythema index or transepidermal water loss on the LED-treated side versus the untreated side.
Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.
Abstract
The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on link.springer.com.
Record from PubMed, a service of the National Library of Medicine.
Light parameters mentioned
Found in the title and abstract by pattern. They may be incomplete, so check the paper before comparing studies.
- Wavelength
- 590 nm
How to read a trial: what to check before relying on this kind of research.
Terms in this paper: Light-emitting diode, Laser, Low-level laser therapy, Wound healing, Phototherapy. Each links to its definition in the glossary.
A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.